Carrying the code of renewal to where healing has stalled. iPSC exosomes reactivate the tissue regeneration cascade in diabetic wounds.
Malaysia has one of the highest diabetes rates in Southeast Asia — over 3.9 million Malaysians live with diabetes. Diabetic foot ulcers and chronic wounds represent one of the most challenging complications, driven by impaired cellular signalling, poor vascularisation, and chronic inflammation.
In diabetic tissue, cells lose their ability to receive and respond to healing signals. iPSC exosomes deliver a concentrated healing payload that bypasses this receptor dysfunction and directly activates the regenerative cascade.
Grade I–III DFUs that have failed to respond to standard wound care. Exosome therapy reactivates the healing cascade.
Chronic venous insufficiency wounds resistant to compression therapy. Exosomes stimulate new tissue formation.
Dehisced or slow-healing surgical wounds. Exosome topical or injectable application accelerates re-epithelialisation.
Stages II–IV pressure injuries in immobilised patients. Exosomes support tissue regeneration from the base of the wound.
Speak with a certified exosome therapy specialist near you.